Author

Kai Hu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Nanomedicine-based strategies to counter chemoresistance in diffuse large B-cell lymphoma.

A review elucidates the molecular insights into the detailed mechanisms of chemoresistance in DLBCL and the developments in nanomedicine as a potential model for precision lymphoma therapy.

Dan-Yang Li, Xiao-Yan Ke, Kai Hu · Biochimica et biophysica act... · 0 citations

Review Open access Jul 2026

Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report and review of the literature

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy with limited therapeutic options for patients ineligible for allogeneic hematopoietic stem cell transplantation (allo-HSCT). While CD123-targeted therapies and CAR T-cell infusion have shown promise, achieving durable remission...

Fan Yang, Dan-Yang Li, Y. Lei et al. · Frontiers in Immunology · 0 citations